pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$NMRANeumora Therapeutics, Inc.

$NMRA
Watertown, MA, USupdated 3mo ago
SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Phase 3: 1
1Phase 3
Phase 3
navacaprant hydrochloride
Major Depressive Disorder

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase3Study to Assess the Safety and Effectiveness of NMRA-335140-501recruitingn=1,000
  • phase3Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorderactive not recruitingn=332
  • phase3Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorderactive not recruitingn=332
  • phase2To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.completedn=18
  • phase3Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disordercompletedn=383
  • phase1Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Diseasecompletedn=96
  • phase2Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebocompletedn=204
🐶 Hiring Signal
1 open role at Neumora Therapeutics, Inc. →

Where Neumora Therapeutics, Inc. is staffing up — a leading indicator of pipeline and commercial priorities.

departmentFinance 1

News

  • Xenon tumbles on voluntary psychiatry hold, but analysts confident in $2B epilepsy opportunity
    As Xenon Pharmaceuticals announced that azetukalner has reached the FDA for focal seizures, the company also disclosed the emergence of psychosis adverse events in psychiatric trials of the drug, t…
    biospace · 13d ago
  • Chutes & Ladders—Neumora shuffles leadership ahead of IND
    Joshua Pinto, Ph.D., has been appointed chief executive officer of Neumora Therapeutics, a clinical-stage biotech with obesity and neuro assets.
    fiercebiotech · 1mo ago
  • Novo’s late-stage IL-6 stumble shakes inflammation space
    Novo Nordisk was banking on the inflammatory benefits of its investigational therapy ziltivekimab to improve cardiovascular outcomes. Last week’s Phase 3 failure dashed not just the Danish pharma’s…
    biospace · 1mo ago
identifiers
ticker
$NMRA
SEC CIK
0001885522
country
US
source
sec_tickers
top tags
Major Depression1
mentioned in
3news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 22m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?